atenolol has been researched along with kt 5720 in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Satake, N; Shibata, M; Shibata, S | 1 |
El-Zohairy, SN; Ezeamuzie, CI; Oriowo, MA | 1 |
2 other study(ies) available for atenolol and kt 5720
Article | Year |
---|---|
The inhibitory effects of iberiotoxin and 4-aminopyridine on the relaxation induced by beta 1- and beta 2-adrenoceptor activation in rat aortic rings.
Topics: 4-Aminopyridine; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Analysis of Variance; Animals; Aorta, Thoracic; Atenolol; Carbazoles; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; Dose-Response Relationship, Drug; Imines; Indoles; Isoproterenol; Male; Muscle Relaxation; Muscle, Smooth, Vascular; Peptides; Propanolamines; Pyrroles; Rats; Scorpion Venoms | 1996 |
Cyclic Adenosine Monophosphate-Mediated Enhancement of Vascular Endothelial Growth Factor Released by Differentiated Human Monocytic Cells: The Role of Protein Kinase A.
Topics: Adrenergic Antagonists; Adrenergic beta-Agonists; Albuterol; Atenolol; Carbazoles; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; Dose-Response Relationship, Drug; Ethanolamines; Humans; Isoproterenol; Lipopolysaccharides; Macrophages; Procaterol; Pyrroles; Vascular Endothelial Growth Factor A | 2015 |